ANNX
Price
$4.88
Change
-$0.18 (-3.56%)
Updated
Dec 17, 04:59 PM (EDT)
92 days until earnings call
FULC
Price
$4.54
Change
+$0.12 (+2.71%)
Updated
Dec 17, 04:59 PM (EDT)
71 days until earnings call
Ad is loading...

ANNX vs FULC

Header iconANNX vs FULC Comparison
Open Charts ANNX vs FULCBanner chart's image
Annexon
Price$4.88
Change-$0.18 (-3.56%)
Volume$22.51K
CapitalizationN/A
Fulcrum Therapeutics
Price$4.54
Change+$0.12 (+2.71%)
Volume$35.87K
CapitalizationN/A
ANNX vs FULC Comparison Chart
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANNX vs. FULC commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a StrongBuy and FULC is a Buy.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ANNX: $4.88 vs. FULC: $4.54)
Brand notoriety: ANNX and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 138% vs. FULC: 142%
Market capitalization -- ANNX: $520.18M vs. FULC: $244.88M
ANNX [@Biotechnology] is valued at $520.18M. FULC’s [@Biotechnology] market capitalization is $244.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, FULC is a better buy in the long-term than ANNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 5 TA indicator(s) are bullish while FULC’s TA Score has 5 bullish TA indicator(s).

  • ANNX’s TA Score: 5 bullish, 4 bearish.
  • FULC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ANNX is a better buy in the short-term than FULC.

Price Growth

ANNX (@Biotechnology) experienced а +0.21% price change this week, while FULC (@Biotechnology) price change was +12.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.83%. For the same industry, the average monthly price growth was +1.09%, and the average quarterly price growth was +9.71%.

Reported Earning Dates

ANNX is expected to report earnings on Mar 20, 2025.

FULC is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (-4.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANNX($520M) has a higher market cap than FULC($245M). ANNX YTD gains are higher at: 7.489 vs. FULC (-32.741). FULC has higher annual earnings (EBITDA): -26.67M vs. ANNX (-129.45M). ANNX has more cash in the bank: 340M vs. FULC (257M). FULC has less debt than ANNX: FULC (9.15M) vs ANNX (29.6M). FULC has higher revenues than ANNX: FULC (80.9M) vs ANNX (0).
ANNXFULCANNX / FULC
Capitalization520M245M212%
EBITDA-129.45M-26.67M485%
Gain YTD7.489-32.741-23%
P/E RatioN/AN/A-
Revenue080.9M-
Total Cash340M257M132%
Total Debt29.6M9.15M324%
TECHNICAL ANALYSIS
Technical Analysis
ANNXFULC
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 20 days ago
84%
Bullish Trend 2 days ago
88%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 7 days ago
87%
View a ticker or compare two or three
Ad is loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVAEX22.32-0.08
-0.36%
Delaware Ivy Asset Strategy Fund Cl I
BOYAX31.14-0.12
-0.38%
Boyar Value
DIVHX27.08-0.13
-0.48%
Cutler Equity Fund
JFCCX35.35-0.30
-0.84%
JHancock Fundamental All Cap Core C
DCCIX31.55-0.40
-1.25%
Delaware Small Cap Core I

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with MGTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
-3.56%
MGTX - ANNX
45%
Loosely correlated
+1.91%
DNTH - ANNX
41%
Loosely correlated
+1.00%
FDMT - ANNX
40%
Loosely correlated
-2.47%
FULC - ANNX
40%
Loosely correlated
+2.71%
XENE - ANNX
39%
Loosely correlated
-0.07%
More

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ONCT. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ONCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+2.71%
ONCT - FULC
55%
Loosely correlated
N/A
SLS - FULC
48%
Loosely correlated
-4.17%
ANNX - FULC
40%
Loosely correlated
-3.56%
VRDN - FULC
39%
Loosely correlated
-3.34%
MLTX - FULC
34%
Loosely correlated
+6.27%
More